Head and Neck and Endocrine Surgery Unit, Alexandria Main University Hospital, Alexandria School of Medicine, Alexandria, Egypt.
World J Surg. 2012 Mar;36(3):598-606. doi: 10.1007/s00268-011-1393-z.
Most research reporting the management of advanced thyroid cancer focuses on major aerodigestive system or vessel involvement. In the present study, we investigated patients with locally advanced thyroid cancers who presented with malignant skin infiltration. The term fungating thyroid cancer (fTC) has been used to describe such a condition.
The study was based on prospective collection of clinical, laboratory, imaging, and pathological data of all patients admitted to the head and neck and endocrine surgery unit, Main University Hospital, Alexandria School of Medicine, during the period April 2005-March 2011.
Eleven patients were referred with fTC, eight of whom had undergone subtotal thyroidectomy for an undiagnosed well-differentiated thyroid cancer (DTC) in another institution. The final pathological diagnosis showed (DTC, n = 3), poorly differentiated thyroid cancer (n = 5), anaplastic cancer (n = 2), and medullary thyroid cancer (n = 1). Extensive resections and reconstruction using flaps (pectoralis major, n = 6; deltopectoral, n = 1; sternocleidomastoid, n = 1) were undertaken. Complete tumor clearance (R0) was achieved in one patient and the others had microscopic (R1, n = 6) or macroscopic (R2, n = 1) residual disease. The three patients who did not undergo operation died within one month of presentation. The latest review of the eight patients who did undergo operation ranged from 3 to 6 months, but their survival remains unknown as access for follow-up was limited.
大多数报道晚期甲状腺癌治疗的研究都集中在主要的气消化道或血管受累方面。在本研究中,我们调查了局部晚期甲状腺癌患者,这些患者有恶性皮肤浸润。术语“蕈样甲状腺癌(fTC)”已被用于描述这种情况。
该研究基于前瞻性收集所有患者的临床、实验室、影像学和病理数据,这些患者于 2005 年 4 月至 2011 年 3 月期间入住亚历山大医学院头颈部和内分泌外科病房。
有 11 名患者被诊断为 fTC,其中 8 名在另一医疗机构因未诊断的分化良好的甲状腺癌(DTC)行甲状腺次全切除术。最终的病理诊断显示(DTC,n = 3)、低分化甲状腺癌(n = 5)、间变性癌(n = 2)和髓样甲状腺癌(n = 1)。采用皮瓣(胸大肌,n = 6;胸三角肌,n = 1;胸锁乳突肌,n = 1)进行广泛切除和重建。1 名患者实现了完全肿瘤清除(R0),其他患者有显微镜下(R1,n = 6)或肉眼下(R2,n = 1)残留肿瘤。未行手术的 3 名患者在就诊后 1 个月内死亡。对 8 名接受手术的患者进行了最新的随访,随访时间从 3 个月到 6 个月不等,但由于随访途径有限,他们的生存情况仍不清楚。